VANCOUVER, Oct. 1, 2013 /CNW/ - MediJean today announced the launch of its medical marijuana research program under a special Research and Development exemption granted by Health Canada. As part of the new Federal Marijuana for Medical Purposes Regulations (MMPR) program, this rarely-granted exemption provides an early-start option for serious Licensed Producer (LP) applicants.
"This exemption puts our company on a strong R&D track right out of the gate," said Anton Mattadeen, Chief Strategy Officer for MediJean. "We began this venture with the goal of building a credible company in an industry undergoing rapid change worldwide. The challenge now is to erase the deep-rooted stigma associated with street-sourced medical marijuana by providing safe, high quality products delivered within an exceptional patient client experience."
By closing the credibility gap and taking the lead in delivering quality medicine to patients, MediJean will help Canada establish a gold standard that all companies in the category should aspire to, and from which the emerging global industry will take its cue. This goal can only be achieved through a dedication to research and development, enhanced by a growing community of research scientists and new partnerships with law enforcement and policy makers.
"The clear difference with our approach is we're not re-labeling questionable street marijuana as medical marijuana," said Mattadeen. "With well over 500 known strains on the existing grey market, we know our method of sourcing, selecting and cultivating only the best plant genetics, coupled with our comprehensive quality assurance controls throughout our production processes, will set us apart and result in superior medicine choices for our patients."
In the coming weeks MediJean will open new discussions and debates around the emerging role of medical marijuana in health sciences and society at large, while sharing more details of its goals, mission and approaches. The company is inviting the public and all interested health professionals to pre-register on the website at http://medijean.com for updates on how to learn about this coming wave of medical marijuana products and services.
MediJean is leading the rebirth of medical marijuana through a laser focus on research, quality and patient experience by implementing best practices here and around the world. Doctors and Nurse Practitioners will understand and safely prescribe it within a clinical framework, patients will have access to clean and affordable medicine, and university research partners will help the company expand the frontiers of medical marijuana in the years ahead.
For further information:
For more information about MediJean please contact:
Media please contact:
Justin Ferguson / 1-800-267-8130